Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the industry. The only way you can have any growth is buy it.

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

Becton Dickinson & Co. closed 28.21% short of its 52-week high of $251.99, which the company reached on February 3rd.

Roundtable (RT) selections published on 7/11/2025 listed 26 dividend picks for 2025. Click for more on Dividend Quick Picks & ...

The US Food and Drug Administration granted clearances for infectious disease tests, digital pathology software, and hematology analyzers, among other in vitro diagnostic technologies.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Waters Corporation (NYSE: WAT) and Becton, ...

Recent developments illustrate dynamic shifts in the healthcare sector. Trump's spending bill is anticipated to challenge ...

Bank of New York Mellon logged higher-than-expected earnings and revenue in the second quarter, helped by its fast-growing net interest income. Dave & Buster's Entertainment named Tarun Lal as chief ...

According to Benzinga Pro, Becton Dickinson's peer group average for short interest as a percentage of float is 4.29%, which ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

Private equity work is up year-over-year, but tariffs, inflation and valuations continue to be an issue for dealmakers.